Position in APGE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,636,500
New position
Shares Held
50,000
first reported quarter
Ownership
0.066%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#108
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vestcor Inc holds $65,816,304 across 34 Biotechnology names. APGE ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,242 | $13,531,918 | |
| 2 | INCY |
Incyte Corp
|
114,821 | $13,016,108 | |
| 3 | EXEL |
Exelixis, Inc.
|
132,700 | $7,220,207 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
This page
|
50,000 | $6,636,500 | |
| 5 | TECH |
BIO-TECHNE Corp
|
90,000 | $6,358,500 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,959 | $2,640,790 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
119,319 | $2,024,843 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,060 | $1,824,241 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,636,500 | 50,000 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||